Endogenous PTH deficiency impairs fracture healing and impedes the Fracture-Healing efficacy of exogenous PTH(1-34)

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Ren, Yongxin ^a   Liu, Bo ^a,b   Feng, Yuxu ^a   Shu, Lei ^a   Cao, Xiaojian ^a   Karaplis, Andrew ^c   Goltzman, David ^c   Miao, Dengshun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Department of Orthopaedics   (China)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE RADIOGRAPHY; BONE REMODELING; CALLUS; CONTROLLED STUDY; DIAPHYSIS; FEMUR FRACTURE; FRACTURE HEALING; HORMONE DEFICIENCY; INTRAMEDULLARY NAILING; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PARATHYROID HORMONE DEFICIENCY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE; ANIMAL; DRUG EFFECT; ENZYME IMMUNOASSAY; FRACTURE; GENETICS; MOUSE MUTANT; OSTEOLYSIS; PATHOLOGY; PHYSIOLOGY; WOUND HEALING;

ANIMALIA; MUS;

ANIMALS; BLOTTING, WESTERN; BONE RESORPTION; BONY CALLUS; FRACTURE HEALING; FRACTURES, BONE; IMMUNOENZYME TECHNIQUES; MICE; MICE, KNOCKOUT; PARATHYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WOUND HEALING;

EID: 79960906055     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023060     Document Type: Article

References (27)

1. Miao D, He B, Karaplis AC, Goltzman D, (2002) Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109: 1173-1182.
2. Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D, (2005) Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum Mol Genet 14: 1515-1528.
3. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, et al. (2001) Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 98: 7498-7503.
4. Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, et al. (2007) Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146: 326-339.
5. Hodsman AB, Hanley DA, Ettinger MP, Bolognese MA, Fox J, et al. (2003) Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 88: 5212-5220.
6. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, et al. (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434-1441.
7. Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, et al. (2005) Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 87: 731-741.
8. Andreassen TT, Ejersted C, Oxlund H, (1999) Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14: 960-968.
9. Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA, (1999) Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop Relat Res pp. 258-263.
10. Kim HW, Jahng JS, (1999) Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Iowa Orthop J 19: 71-77.
11. Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, et al. (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17: 2038-2047.
12. Jahng JS, Kim HW, (2000) Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics 23: 1089-1094.
13. Miao D, He B, Lanske B, Bai XY, Tong XK, et al. (2004) Skeletal abnormalities in Pth-null mice are influenced by dietary calcium. Endocrinology 145: 2046-2053.
14. Schmidmaier G, Wildemann B, Melis B, Krummrey G, Einhorn TA, et al. (2004) Development and characterization of a standard closed tibial fracture model in the rat. European Journal of Trauma 30: 35-42.
15. Liu H, Guo J, Wang L, Chen N, Karaplis A, et al. (2009) Distinctive anabolic roles of 1,25-dihydroxyvitamin D(3) and parathyroid hormone in teeth and mandible versus long bones. J Endocrinol 203: 203-213.
16. Sun W, Liu J, Zhou X, Xiao Y, Karaplis A, et al. (2010) Alterations in phosphorus, calcium and PTHrP contribute to defects in dental and dental alveolar bone formation in calcium-sensing receptor-deficient mice. Development 137: 985-992.
17. Miao D, Bai X, Panda D, McKee M, Karaplis A, et al. (2001) Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 142: 926-939.
18. Panda DK, Miao D, Bolivar I, Li J, Huo R, et al. (2004) Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279: 16754-16766.
19. Miao D, Scutt A, (2002) Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 50: 333-340.
20. Miao D, Scutt A, (2002) Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3 in vivo. BMC Musculoskelet Disord 3: 16.
21. Fukuhara H, Mizuno K, (1989) [The influence of parathyroid hormone on the process of fracture healing]. Nippon Seikeigeka Gakkai Zasshi 63: 100-115.
22. Nakazawa T, Nakajima A, Shiomi K, Moriya H, Einhorn TA, et al. (2005) Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Bone 37: 711-719.
23. Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, et al. (2007) Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22: 1903-1912.
24. Law WM Jr, Heath H III, (1984) Increased renal responses to exogenous parathyroid hormone in postsurgical hypoparathyroidism. J Clin Endocrinol Metab 59: 394-397.
25. Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, et al. (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70: 930-938.
26. Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, et al. (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4: 283-291.
27. Zhou H, Shen V, Dempster DW, Lindsay R, (2001) Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 16: 1300-1307.